HCLTech launches AI-Powered Operations for mainframe environments

HCLTech, a leading global technology company, announced the launch of its AI-Powered Operations offering, designed to help enterprises modernize and optimize their mission-critical mainframe environments through AI-enabled automation, observability and operational intelligence.

The offering brings together specialized mainframe skill agents and conversational AI assistants to support system administration, observability, optimization and workflows, under human oversight. These capabilities help improve efficiency, accelerate issue resolution and enable more proactive, insight-driven operations. HCLTech's dedicated Mainframe Center of Excellence underpins the offering with deep domain expertise, industry best practices and continued innovation.

"Enterprises running mission-critical workloads on mainframes are under increasing pressure to modernize operations and drive greater efficiency, without compromising reliability or control. Our AI-Powered Operations offering directly addresses this business need, combining HCLTech's deep mainframe expertise with AI-driven capabilities to help clients simplify operations, reduce risk and unlock greater value from their mainframe investments as they advance their broader transformation agendas," said Rampal Singh, Senior Vice President and Global Business Head of Hybrid Cloud at HCLTech.

"AI is fundamentally changing how enterprises manage and extract value from their most strategic technology platforms. Through our dedicated Mainframe Center of Excellence and AI innovation capabilities, we are embedding intelligent agents and operational intelligence directly into mainframe environments, enabling organizations to shift from reactive management to proactive, insight-driven operations, while preserving the security, resilience and governance these platforms demand," said Raghu Kidambi, Corporate Vice President and Head of AI Ecosystems at HCLTech.

 

 

Comments

Post a Comment

Popular posts from this blog

A graphic novel about Anglo-Indian heritage with stunning illustrations

Image
The launch event for The History of Anglo-Indians: A Graphic Novel, a profound exploration of heritage, identity, and untold stories, was held on Saturday, August 8, 2026, at the C.P. Arts Convention Centre on Eldams Road in Chennai. The evening featured Dr. Oscar C. Nigli, the Senior National Vice-President of the All-India Anglo-Indian Association, as the esteemed special guest. Dr. Nigli is also a former Dean and Professor at Loyola College in Chennai, as well as a Former Anglo-Indian Member of the Legislative Assembly in Tamil Nadu. Attendees were treated to an insightful presentation by Keith Butler, who shared the research and creative journey behind The History of Anglo-Indians, followed by a discussion with the author. The graphic novel is brought to life by the stunning illustrations of Harry MacLure, a talented writer, cartoonist, artist, and comic book illustrator based in Chennai. MacLure is well known for his role as the editor of Anglos In The Wind, the longest-running ...
Read more

Apollo Cancer Centers now introduces Made in India, CAR T Cell Program

Image
First Private Hospital in India to Successfully Complete CAR T Cell Therapy.  In a ground-breaking development, Apollo Cancer Centres (ACCs) has emerged as the first private hospital group in India to have a successfully complete CAR-T cell program and to further augment it, the group will now provide access to Made in India CAR-T cell therapy, beginning with NexCAR19 (Actalycabtagene autoleucel), for the treatment of B-cell lymphomas and B-acute lymphoblastic leukaemia in patients aged 15 years and above.   Marking a historic moment in the country's medical landscape , Dr. T Raja, Director of Medical Oncology at ACC, Chennai, spearheaded the development of this revolutionary clinical program, and has successfully treated six patients till date.   CAR-T cell therapies, often known as living drugs involve the extraction of a patients T-cells (a type of white blood cells whose function is to fight cancer cells) through a process known as Apheresis. These T-cells are t...
Read more

Gleneagles Hospital Successfully Treats Rare CNS (Brain) Lymphoma with Advanced CAR-T Cell Therapy

Image
Gleneagles Hospital Chennai, a part of Fortis Healthcare, has successfully treated a 49-year-old patient from Andhra Pradesh diagnosed with a rare and aggressive form of CNS(brain) lymphoma using advanced CAR-T cell therapy. Despite developing multiple serious treatment-related complications, the patient achieved complete remission and is doing well. The patient presented with complaints of persistent headache, giddiness, difficulty in walking, and weakness in his left arm and leg. Detailed investigations confirmed Primary Central Nervous System Lymphoma (PCNSL) , a rare type of lymphoma that affects the brain and is known to be difficult to treat. The patient initially received high-dose chemotherapy, the standard first-line treatment for this condition. However, the disease continued to progress despite four cycles of treatment. He subsequently underwent radiotherapy with chemotherapy, followed by oral targeted therapy as bridging treatment. As the lymphoma remained resistant to ...
Read more